Atea Pharmaceuticals, Inc.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
9/10
|
11.38 | 48.77 | -76.67% | -62.13 | -118.32% |
| P/S |
|
1.7 | 33.76 | -94.96% |
|
|
| P/BV |
|
0.4776 | 4.82 | -90.09% |
|
|
| P/FCF |
|
-3.26 | 60.98 | -105.35% |
|
|
| Ev/Ebitda |
|
-0.7558 | -22.12 | -96.58% |
|
|
| Ev/S |
|
0.6439 | 22.56 | -97.15% |
|
|
| Ev/FCF |
|
-1.45 | 68.75 | -102.11% |
|
|
| E/P |
|
-0.488 | 0.0178 | -2845.63% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
5/10
|
15.83 | 4.83 | 227.72% | -17.04 | -192.92% |
| ROE |
|
-24.49 | 9.61 | -354.92% |
|
|
| ROA |
|
-22.85 | 0.3359 | -6902.8% |
|
|
| ROIC |
|
7.58 | 7.63 | -0.712% |
|
|
| ROS |
|
-70.74 | -25.17 | 181.05% |
|
|
| ROCE |
|
-29.57 | 15.33 | -292.87% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
-0.0147 | -3.67 | -99.6% | -0.0143 | 2.42% |
| Nеt Debt/Ebitda |
|
0.8637 | -3.44 | -125.11% |
|
|
| Debt/Ratio |
|
0.004 | 0.1972 | -97.95% |
|
|
| Debt/Equity |
|
0.0036 | 1.65 | -99.78% |
|
|
| Debt/Net Income |
|
-0.0177 | 10.31 | -100.17% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 0.5491 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 0.0789 | -100% |
|
|
| DSI |
|
0 | 0.2043 | -100% |
|
|
| Average dividend growth |
|
0 | 0.0591 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 0.4924 | -100% |
|
|
| Average percentage for payments |
|
0 | 43.56 | -100% |
|
|
| Difference from average difference in sector |
|
-0.5491 |
|
|
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % |
|---|---|---|---|---|
| Growth impulse Revenue 5 years |
10/10
|
295.43 | -56.89 | -619.3% |
| Growth impulse Ebitda 5 years |
|
719.13 | -64.81 | -1209.6% |
| Growth impulse Net Income 5 years |
|
907.08 | -58.33 | -1655.08% |
| Growth impulse FCF 5 years |
|
567.15 | -47 | -1306.7% |
| Growth impulse EPS 5 years |
|
472.86 | -32.41 | -1558.99% |
IP Score
5.62/10
